Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • プラットフォームと自動化
  • イメージング
  • In vivo イメージング
  • In Vivo Imaging Reagents
  • IVISense Fluorescent Panels
  • IVISense Toxicology Fluorescent Imaging Panel

IVISense Toxicology Fluorescent Imaging Panel

IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense Toxicology Fluorescent Imaging Panel
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel containing 6 probes to detect drug toxicity. Example image of drug induced liver injury (DILI) in a mouse model.
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox

IVISense™ Toxicology Fluorescent Imaging Panel is designed to detect drug-induced liver injury (DILI) early in the drug discovery process. DILI is a leading cause of project termination. The panel allows researchers to image inflammation, tissue destruction, metabolic changes, and vascular leak (edema). By measuring these biological changes prior to overt histological signs, the panel provides predictive data on potential drug toxicity.

View product information

IVISense™ Toxicology Fluorescent Imaging Panel is designed to detect drug-induced liver injury (DILI) early in the drug discovery process. DILI is a leading cause of project termination. The panel allows researchers to image inflammation, tissue destruction, metabolic changes, and vascular leak (edema). By measuring these biological changes prior to overt histological signs, the panel provides predictive data on potential drug toxicity.

View product information
Product variant
Unit Size: 1 kit containing 5 vials
Part #:
NEV20016
For research use only. Not for use in diagnostic procedures.
Request more information
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense Toxicology Fluorescent Imaging Panel
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel containing 6 probes to detect drug toxicity. Example image of drug induced liver injury (DILI) in a mouse model.
IVISense Toxicology Fluorescent Imaging Panel
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
IVISense™ Toxicology Fluorescent Imaging Panel
Liver Tox
Quick links
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Get help

Product information

  • Overview
  • Additional product information
  • Specifications

Overview

Our Toxicology Fluorescent Imaging Panel of probes allows you to image inflammation, tissue destruction, metabolic changes, and vascular leak (edema), in a manner that can be predictive of potential drug toxicity, measuring biological changes prior to overt histological signs. Our published research shows the utility of a three-probe cocktail for imaging drug-induced liver injury (Vasquez & Peterson, J Pharmacol Exp Ther 2017; 361:87-98) via a ratio of probes specifically designed to optimize liver injury signal while minimizing normal background signal in liver and kidneys. The Toxicology Panel provides an extra vial of IVISense MMP 750 FAST to allow the preparation of the cocktail.

The inclusion of probes at 680 nm and 750 nm wavelengths further offers the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.

Additional product information

Our IVISense toxicology fluorescent imaging panel includes the following five probes (6 vials)
Part number Fluorescent probe Biological target
NEV10054EX IVISense Vascular 680 (AngioSense 680EX) Vascular probe:
Leaks into sites of vascular damage or inflammation
NEV10091 IVISense Transferrin Receptor 750  (Transferrin-Vivo 750) Transferrin receptor targeted probe:
Iron metabolism marker in liver
NEV10168 x 2 IVISense MMP 750 FAST  (MMPSense 750 FAST) Pan-MMP activatable probe:
Secreted marker of stellate cells, Kupffer cells, macrophages, and neutrophils
NEV11053 IVISense Annexin-V 750 Fluorescent Probe (Annexin-Vivo) Death/apoptosis probe:
Marker on inflammatory cells; metabolic marker on tumor cells
NEV11079 IVISense Renin 680 FAST (ReninSense 680 FAST) Renin activatable probe:
Marker of tissue renin-angiotensin system activity

 

Specifications

Brand
IVISense
Imaging Modality
Fluorescence
Shipping Conditions
Shipped in Blue Ice
Storage Conditions
+2 to +8 °C
Therapeutic Area
Toxicology
Unit Size
1 kit containing 5 vials

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Application Brief:-:1
  • eBook:-:1
  • Flyer:-:1
  • Guide:-:1
  • Protocol/SOP:-:1
1-1 of 1 Resources
Protocol/SOP
Protocol/SOP
IVISense fluorescent imaging panels user guide
Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.